Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study

Zhirong Yang,1 Duncan Edwards,1 Efthalia Massou,1 Catherine L Saunders,1 Carol Brayne,2 Jonathan Mant11Primary Care Unit, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK; 2Institute of Public Health, School of Clinical Medicine, Unive...

Full description

Bibliographic Details
Main Authors: Yang Z, Edwards D, Massou E, Saunders CL, Brayne C, Mant J
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Clinical Epidemiology
Subjects:
Online Access:https://www.dovepress.com/statin-use-and-high-dose-statin-use-after-ischemic-stroke-in-the-uk-a--peer-reviewed-article-CLEP
_version_ 1818322735053406208
author Yang Z
Edwards D
Massou E
Saunders CL
Brayne C
Mant J
author_facet Yang Z
Edwards D
Massou E
Saunders CL
Brayne C
Mant J
author_sort Yang Z
collection DOAJ
description Zhirong Yang,1 Duncan Edwards,1 Efthalia Massou,1 Catherine L Saunders,1 Carol Brayne,2 Jonathan Mant11Primary Care Unit, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK; 2Institute of Public Health, School of Clinical Medicine, University of Cambridge, Cambridge, UKBackground: Trial evidence supports statin use after ischemic stroke and recent American, European and British guidelines recommend high-intensity statins for this indication. Limited data are available describing current statin use among these patients in unselected settings. We conducted a cohort study to examine secular trends and factors associated with statin use and dose following ischemic stroke.Methods: A retrospective cohort study of patients with first ischemic stroke between 2000 and 2014 was conducted using the Clinical Practice Research Datalink (CPRD). Proportions of statin users and high-intensity statin users within 2 years after stroke were estimated for each calendar year. We used Cox regression models to explore potential factors associated with statin use and Poisson regression models to calculate risk ratios for the use of a high-intensity statin.Results: A total of 80,442 patients with first stroke were analyzed. The proportion using statins within 2 years after stroke increased from 25% in 2000 to 70% in 2006 and remained at about 75% through 2014. Among post-stroke statin users, high-intensity use accounted for approximately 15% between 2004 and 2011 and then increased to almost 35% in 2014. Older patients (aged ≥75 years), younger patients (<45 years), patients with no prior statin treatment, dementia, underweight, or absence of cardiovascular factors (coronary heart disease, smoking, obesity, diabetes, hypertension, or transient ischemic attack) were less likely to use statins and less likely to receive a high-intensity statin.Conclusion: There has been an increase over time in both statin use and dose, but many patients with ischemic stroke continue to be under-treated. Clinical trials and policy interventions to improve appropriate post-stroke statin use should focus on younger and older patients, patients with no pre-stroke statin treatment, and patients without additional cardiovascular risk factors.Keywords: cerebral ischemia, lipid-lowering, trend, factors
first_indexed 2024-12-13T11:01:31Z
format Article
id doaj.art-54a533aee3554bac81af857475c70720
institution Directory Open Access Journal
issn 1179-1349
language English
last_indexed 2024-12-13T11:01:31Z
publishDate 2019-06-01
publisher Dove Medical Press
record_format Article
series Clinical Epidemiology
spelling doaj.art-54a533aee3554bac81af857475c707202022-12-21T23:49:14ZengDove Medical PressClinical Epidemiology1179-13492019-06-01Volume 1149550846705Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort studyYang ZEdwards DMassou ESaunders CLBrayne CMant JZhirong Yang,1 Duncan Edwards,1 Efthalia Massou,1 Catherine L Saunders,1 Carol Brayne,2 Jonathan Mant11Primary Care Unit, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK; 2Institute of Public Health, School of Clinical Medicine, University of Cambridge, Cambridge, UKBackground: Trial evidence supports statin use after ischemic stroke and recent American, European and British guidelines recommend high-intensity statins for this indication. Limited data are available describing current statin use among these patients in unselected settings. We conducted a cohort study to examine secular trends and factors associated with statin use and dose following ischemic stroke.Methods: A retrospective cohort study of patients with first ischemic stroke between 2000 and 2014 was conducted using the Clinical Practice Research Datalink (CPRD). Proportions of statin users and high-intensity statin users within 2 years after stroke were estimated for each calendar year. We used Cox regression models to explore potential factors associated with statin use and Poisson regression models to calculate risk ratios for the use of a high-intensity statin.Results: A total of 80,442 patients with first stroke were analyzed. The proportion using statins within 2 years after stroke increased from 25% in 2000 to 70% in 2006 and remained at about 75% through 2014. Among post-stroke statin users, high-intensity use accounted for approximately 15% between 2004 and 2011 and then increased to almost 35% in 2014. Older patients (aged ≥75 years), younger patients (<45 years), patients with no prior statin treatment, dementia, underweight, or absence of cardiovascular factors (coronary heart disease, smoking, obesity, diabetes, hypertension, or transient ischemic attack) were less likely to use statins and less likely to receive a high-intensity statin.Conclusion: There has been an increase over time in both statin use and dose, but many patients with ischemic stroke continue to be under-treated. Clinical trials and policy interventions to improve appropriate post-stroke statin use should focus on younger and older patients, patients with no pre-stroke statin treatment, and patients without additional cardiovascular risk factors.Keywords: cerebral ischemia, lipid-lowering, trend, factorshttps://www.dovepress.com/statin-use-and-high-dose-statin-use-after-ischemic-stroke-in-the-uk-a--peer-reviewed-article-CLEPcerebral ischemialipid-loweringtrendfactors
spellingShingle Yang Z
Edwards D
Massou E
Saunders CL
Brayne C
Mant J
Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study
Clinical Epidemiology
cerebral ischemia
lipid-lowering
trend
factors
title Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study
title_full Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study
title_fullStr Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study
title_full_unstemmed Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study
title_short Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study
title_sort statin use and high dose statin use after ischemic stroke in the uk a retrospective cohort study
topic cerebral ischemia
lipid-lowering
trend
factors
url https://www.dovepress.com/statin-use-and-high-dose-statin-use-after-ischemic-stroke-in-the-uk-a--peer-reviewed-article-CLEP
work_keys_str_mv AT yangz statinuseandhighdosestatinuseafterischemicstrokeintheukaretrospectivecohortstudy
AT edwardsd statinuseandhighdosestatinuseafterischemicstrokeintheukaretrospectivecohortstudy
AT massoue statinuseandhighdosestatinuseafterischemicstrokeintheukaretrospectivecohortstudy
AT saunderscl statinuseandhighdosestatinuseafterischemicstrokeintheukaretrospectivecohortstudy
AT braynec statinuseandhighdosestatinuseafterischemicstrokeintheukaretrospectivecohortstudy
AT mantj statinuseandhighdosestatinuseafterischemicstrokeintheukaretrospectivecohortstudy